Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
BATF
|
ENSG00000156127.6 | basic leucine zipper ATF-like transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BATF | hg19_v2_chr14_+_75988768_75988826 | 0.27 | 1.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_89340242 | 7.87 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr4_+_40192656 | 7.57 |
ENST00000505618.1
|
RHOH
|
ras homolog family member H |
chr22_+_23010756 | 7.34 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
chr2_+_89998789 | 6.58 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr2_+_90198535 | 6.54 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr22_+_23029188 | 6.39 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
chr2_-_89521942 | 6.37 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
chr22_+_22749343 | 6.08 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
chr2_-_89266286 | 5.82 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr2_+_90259593 | 5.70 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr22_+_22723969 | 5.58 |
ENST00000390295.2
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 (gene/pseudogene) |
chr2_+_90139056 | 5.48 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr14_-_94854926 | 5.43 |
ENST00000402629.1
ENST00000556091.1 ENST00000554720.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr7_+_142028105 | 5.42 |
ENST00000390353.2
|
TRBV6-1
|
T cell receptor beta variable 6-1 |
chr2_-_89417335 | 5.31 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr2_+_89901292 | 5.04 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr2_+_102618428 | 4.99 |
ENST00000457817.1
|
IL1R2
|
interleukin 1 receptor, type II |
chr2_+_89999259 | 4.93 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr3_+_151531810 | 4.68 |
ENST00000232892.7
|
AADAC
|
arylacetamide deacetylase |
chr17_-_38721711 | 4.63 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
chr14_-_107078851 | 4.37 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
chr22_+_22385332 | 4.28 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr2_+_90192768 | 4.27 |
ENST00000390275.2
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
chr22_+_23089870 | 4.12 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr5_+_35856951 | 3.95 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr1_+_160709076 | 3.93 |
ENST00000359331.4
ENST00000495334.1 |
SLAMF7
|
SLAM family member 7 |
chr14_-_106967788 | 3.91 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr22_+_23063100 | 3.81 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr22_+_23054174 | 3.80 |
ENST00000390308.2
|
IGLV3-21
|
immunoglobulin lambda variable 3-21 |
chr14_-_106963409 | 3.78 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
chr22_-_37545972 | 3.78 |
ENST00000216223.5
|
IL2RB
|
interleukin 2 receptor, beta |
chr14_-_25103472 | 3.75 |
ENST00000216341.4
ENST00000382542.1 ENST00000382540.1 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr7_-_142511084 | 3.73 |
ENST00000417977.2
|
TRBV30
|
T cell receptor beta variable 30 (gene/pseudogene) |
chr14_+_22386325 | 3.64 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
chr2_-_89619904 | 3.62 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr1_+_160709029 | 3.58 |
ENST00000444090.2
ENST00000441662.2 |
SLAMF7
|
SLAM family member 7 |
chr9_-_137809718 | 3.55 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
chr1_-_157746909 | 3.48 |
ENST00000392274.3
ENST00000361516.3 ENST00000368181.4 |
FCRL2
|
Fc receptor-like 2 |
chr5_+_54320078 | 3.47 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
chr1_+_168545711 | 3.43 |
ENST00000367818.3
|
XCL1
|
chemokine (C motif) ligand 1 |
chr9_-_34710066 | 3.41 |
ENST00000378792.1
ENST00000259607.2 |
CCL21
|
chemokine (C-C motif) ligand 21 |
chr12_+_103981044 | 3.34 |
ENST00000388887.2
|
STAB2
|
stabilin 2 |
chr22_+_22712087 | 3.32 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr4_+_156775910 | 3.26 |
ENST00000506072.1
ENST00000507590.1 |
TDO2
|
tryptophan 2,3-dioxygenase |
chr3_-_58196688 | 3.25 |
ENST00000486455.1
|
DNASE1L3
|
deoxyribonuclease I-like 3 |
chr22_+_23161491 | 3.19 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
chr2_-_89310012 | 3.19 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr14_+_22362613 | 3.18 |
ENST00000390438.2
|
TRAV8-4
|
T cell receptor alpha variable 8-4 |
chr1_-_153348067 | 3.15 |
ENST00000368737.3
|
S100A12
|
S100 calcium binding protein A12 |
chr9_+_117085336 | 3.10 |
ENST00000259396.8
ENST00000538816.1 |
ORM1
|
orosomucoid 1 |
chr11_-_118213455 | 3.10 |
ENST00000300692.4
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
chr14_+_22337014 | 3.09 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
chr2_+_89184868 | 3.09 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
chr6_-_133084580 | 3.08 |
ENST00000525270.1
ENST00000530536.1 ENST00000524919.1 |
VNN2
|
vanin 2 |
chr14_-_94857004 | 3.01 |
ENST00000557492.1
ENST00000448921.1 ENST00000437397.1 ENST00000355814.4 ENST00000393088.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr1_+_160709055 | 3.00 |
ENST00000368043.3
ENST00000368042.3 ENST00000458602.2 ENST00000458104.2 |
SLAMF7
|
SLAM family member 7 |
chr14_-_25103388 | 2.97 |
ENST00000526004.1
ENST00000415355.3 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr14_-_94856987 | 2.97 |
ENST00000449399.3
ENST00000404814.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr4_+_40201954 | 2.96 |
ENST00000511121.1
|
RHOH
|
ras homolog family member H |
chr4_-_74847800 | 2.96 |
ENST00000296029.3
|
PF4
|
platelet factor 4 |
chr19_+_46009837 | 2.94 |
ENST00000589627.1
|
VASP
|
vasodilator-stimulated phosphoprotein |
chr2_+_89923550 | 2.92 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
chr14_+_22314715 | 2.90 |
ENST00000390434.3
|
TRAV8-2
|
T cell receptor alpha variable 8-2 |
chr3_+_151531859 | 2.89 |
ENST00000488869.1
|
AADAC
|
arylacetamide deacetylase |
chr3_+_30648066 | 2.88 |
ENST00000359013.4
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr3_+_30647994 | 2.88 |
ENST00000295754.5
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr4_-_155511887 | 2.83 |
ENST00000302053.3
ENST00000403106.3 |
FGA
|
fibrinogen alpha chain |
chr3_-_42917363 | 2.82 |
ENST00000437102.1
|
CYP8B1
|
cytochrome P450, family 8, subfamily B, polypeptide 1 |
chr7_-_142247606 | 2.82 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
chr10_+_81370689 | 2.80 |
ENST00000372308.3
ENST00000398636.3 ENST00000428376.2 ENST00000372313.5 ENST00000419470.2 ENST00000429958.1 ENST00000439264.1 |
SFTPA1
|
surfactant protein A1 |
chr12_-_15104040 | 2.80 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr16_-_71610985 | 2.72 |
ENST00000355962.4
|
TAT
|
tyrosine aminotransferase |
chr2_+_98330009 | 2.67 |
ENST00000264972.5
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa |
chr7_-_38398721 | 2.66 |
ENST00000390346.2
|
TRGV3
|
T cell receptor gamma variable 3 |
chr17_+_48712206 | 2.66 |
ENST00000427699.1
ENST00000285238.8 |
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
chr19_-_19739321 | 2.65 |
ENST00000588461.1
|
LPAR2
|
lysophosphatidic acid receptor 2 |
chr16_+_33629600 | 2.63 |
ENST00000562905.2
|
IGHV3OR16-13
|
immunoglobulin heavy variable 3/OR16-13 (non-functional) |
chr22_+_23241661 | 2.58 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr1_-_159046617 | 2.56 |
ENST00000368130.4
|
AIM2
|
absent in melanoma 2 |
chr9_-_116840728 | 2.55 |
ENST00000265132.3
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
chr2_+_90060377 | 2.55 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr2_-_89513402 | 2.55 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr2_-_89247338 | 2.52 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr1_+_17634689 | 2.51 |
ENST00000375453.1
ENST00000375448.4 |
PADI4
|
peptidyl arginine deiminase, type IV |
chr10_+_30723533 | 2.50 |
ENST00000413724.1
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr10_+_5090940 | 2.49 |
ENST00000602997.1
|
AKR1C3
|
aldo-keto reductase family 1, member C3 |
chr16_+_30194118 | 2.48 |
ENST00000563778.1
|
CORO1A
|
coronin, actin binding protein, 1A |
chr19_+_42381337 | 2.47 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr6_-_133084564 | 2.45 |
ENST00000532012.1
|
VNN2
|
vanin 2 |
chr19_+_42381173 | 2.45 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr22_+_23134974 | 2.45 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr1_+_158900568 | 2.44 |
ENST00000458222.1
|
PYHIN1
|
pyrin and HIN domain family, member 1 |
chr16_+_31366536 | 2.44 |
ENST00000562522.1
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit) |
chr11_-_57177586 | 2.42 |
ENST00000529411.1
|
RP11-872D17.8
|
Uncharacterized protein |
chr14_+_22265444 | 2.41 |
ENST00000390430.2
|
TRAV8-1
|
T cell receptor alpha variable 8-1 |
chr11_-_118213360 | 2.40 |
ENST00000529594.1
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
chr4_+_74275057 | 2.39 |
ENST00000511370.1
|
ALB
|
albumin |
chr2_+_114163945 | 2.38 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr12_-_96390108 | 2.36 |
ENST00000538703.1
ENST00000261208.3 |
HAL
|
histidine ammonia-lyase |
chr14_-_106331447 | 2.36 |
ENST00000390564.2
|
IGHJ2
|
immunoglobulin heavy joining 2 |
chr11_-_18258342 | 2.36 |
ENST00000278222.4
|
SAA4
|
serum amyloid A4, constitutive |
chr6_-_32784687 | 2.33 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
chr2_+_113875466 | 2.32 |
ENST00000361779.3
ENST00000259206.5 ENST00000354115.2 |
IL1RN
|
interleukin 1 receptor antagonist |
chr22_+_22707260 | 2.32 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
chr15_+_89181974 | 2.31 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr3_-_27764190 | 2.29 |
ENST00000537516.1
|
EOMES
|
eomesodermin |
chr2_-_89597542 | 2.29 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
chr22_+_22453093 | 2.29 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr17_-_43502987 | 2.28 |
ENST00000376922.2
|
ARHGAP27
|
Rho GTPase activating protein 27 |
chr6_+_131894284 | 2.27 |
ENST00000368087.3
ENST00000356962.2 |
ARG1
|
arginase 1 |
chr17_-_29641104 | 2.27 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
chr2_-_89385283 | 2.27 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr22_+_23165153 | 2.26 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr14_+_21359558 | 2.25 |
ENST00000304639.3
|
RNASE3
|
ribonuclease, RNase A family, 3 |
chr19_-_54872556 | 2.25 |
ENST00000444687.1
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
chr17_-_29641084 | 2.24 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr7_+_142031986 | 2.24 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
chr6_-_137539651 | 2.24 |
ENST00000543628.1
|
IFNGR1
|
interferon gamma receptor 1 |
chr12_-_53594227 | 2.24 |
ENST00000550743.2
|
ITGB7
|
integrin, beta 7 |
chr2_-_89545079 | 2.24 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
chr8_-_123706338 | 2.23 |
ENST00000521608.1
|
RP11-973F15.1
|
long intergenic non-protein coding RNA 1151 |
chr17_-_34207295 | 2.23 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
chr19_-_15575369 | 2.22 |
ENST00000343625.7
|
RASAL3
|
RAS protein activator like 3 |
chr7_+_80231466 | 2.21 |
ENST00000309881.7
ENST00000534394.1 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr2_-_158345462 | 2.20 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
chr15_+_89182156 | 2.20 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr2_-_89292422 | 2.19 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr4_-_100140331 | 2.19 |
ENST00000407820.2
ENST00000394897.1 ENST00000508558.1 ENST00000394899.2 |
ADH6
|
alcohol dehydrogenase 6 (class V) |
chr7_-_142131914 | 2.18 |
ENST00000390375.2
|
TRBV5-6
|
T cell receptor beta variable 5-6 |
chr4_-_84035905 | 2.18 |
ENST00000311507.4
|
PLAC8
|
placenta-specific 8 |
chr19_+_51645556 | 2.17 |
ENST00000601682.1
ENST00000317643.6 ENST00000305628.7 ENST00000600577.1 |
SIGLEC7
|
sialic acid binding Ig-like lectin 7 |
chr14_-_106114739 | 2.17 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
chr2_+_90043607 | 2.16 |
ENST00000462693.1
|
IGKV2D-24
|
immunoglobulin kappa variable 2D-24 (non-functional) |
chr2_+_90229045 | 2.15 |
ENST00000390278.2
|
IGKV1D-42
|
immunoglobulin kappa variable 1D-42 (non-functional) |
chr8_-_17752912 | 2.15 |
ENST00000398054.1
ENST00000381840.2 |
FGL1
|
fibrinogen-like 1 |
chr14_-_25078864 | 2.14 |
ENST00000216338.4
ENST00000557220.2 ENST00000382548.4 |
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX) |
chr7_+_142334156 | 2.14 |
ENST00000390394.3
|
TRBV20-1
|
T cell receptor beta variable 20-1 |
chr4_+_40198527 | 2.14 |
ENST00000381799.5
|
RHOH
|
ras homolog family member H |
chr14_+_21249200 | 2.13 |
ENST00000304677.2
|
RNASE6
|
ribonuclease, RNase A family, k6 |
chr22_+_23077065 | 2.12 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
chr16_+_57023406 | 2.11 |
ENST00000262510.6
ENST00000308149.7 ENST00000436936.1 |
NLRC5
|
NLR family, CARD domain containing 5 |
chr16_+_30194293 | 2.11 |
ENST00000561815.1
|
CORO1A
|
coronin, actin binding protein, 1A |
chr14_+_22465771 | 2.10 |
ENST00000390445.2
|
TRAV17
|
T cell receptor alpha variable 17 |
chr7_+_150688166 | 2.10 |
ENST00000461406.1
|
NOS3
|
nitric oxide synthase 3 (endothelial cell) |
chr10_-_54531406 | 2.10 |
ENST00000373968.3
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble |
chr12_-_10282836 | 2.10 |
ENST00000304084.8
ENST00000353231.5 ENST00000525605.1 |
CLEC7A
|
C-type lectin domain family 7, member A |
chr3_+_63953415 | 2.09 |
ENST00000484332.1
|
ATXN7
|
ataxin 7 |
chr22_+_23101182 | 2.09 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr1_+_160765947 | 2.08 |
ENST00000263285.6
ENST00000368039.2 |
LY9
|
lymphocyte antigen 9 |
chr20_+_44637526 | 2.08 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr12_-_10282742 | 2.08 |
ENST00000298523.5
ENST00000396484.2 ENST00000310002.4 |
CLEC7A
|
C-type lectin domain family 7, member A |
chr1_-_160492994 | 2.07 |
ENST00000368055.1
ENST00000368057.3 ENST00000368059.3 |
SLAMF6
|
SLAM family member 6 |
chr7_-_38339890 | 2.06 |
ENST00000390341.2
|
TRGV10
|
T cell receptor gamma variable 10 (non-functional) |
chr12_-_96389702 | 2.06 |
ENST00000552509.1
|
HAL
|
histidine ammonia-lyase |
chrY_+_15016725 | 2.05 |
ENST00000336079.3
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr17_+_1646130 | 2.04 |
ENST00000453066.1
ENST00000324015.3 ENST00000450523.2 ENST00000453723.1 ENST00000382061.4 |
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
chr9_-_97402531 | 2.04 |
ENST00000415431.1
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
chr22_+_23114284 | 2.03 |
ENST00000390313.2
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
chr4_-_70361615 | 2.03 |
ENST00000305107.6
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4 |
chr19_-_47128294 | 2.02 |
ENST00000596260.1
ENST00000597185.1 ENST00000598865.1 ENST00000594275.1 ENST00000291294.2 |
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP) |
chr22_+_23040274 | 2.02 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr8_-_17752996 | 2.01 |
ENST00000381841.2
ENST00000427924.1 |
FGL1
|
fibrinogen-like 1 |
chr9_-_33447584 | 2.01 |
ENST00000297991.4
|
AQP3
|
aquaporin 3 (Gill blood group) |
chr12_+_69742121 | 2.00 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
chr11_-_102595681 | 2.00 |
ENST00000236826.3
|
MMP8
|
matrix metallopeptidase 8 (neutrophil collagenase) |
chr4_+_74606223 | 1.98 |
ENST00000307407.3
ENST00000401931.1 |
IL8
|
interleukin 8 |
chr6_+_159084188 | 1.98 |
ENST00000367081.3
|
SYTL3
|
synaptotagmin-like 3 |
chr11_+_60869867 | 1.98 |
ENST00000347785.3
|
CD5
|
CD5 molecule |
chr14_+_22694606 | 1.97 |
ENST00000390463.3
|
TRAV36DV7
|
T cell receptor alpha variable 36/delta variable 7 |
chr12_-_57872336 | 1.97 |
ENST00000552066.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
chr1_+_159770292 | 1.97 |
ENST00000536257.1
ENST00000321935.6 |
FCRL6
|
Fc receptor-like 6 |
chr7_-_94953878 | 1.97 |
ENST00000222381.3
|
PON1
|
paraoxonase 1 |
chr10_-_6019984 | 1.96 |
ENST00000525219.2
|
IL15RA
|
interleukin 15 receptor, alpha |
chr11_-_118213331 | 1.96 |
ENST00000392884.2
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
chr12_+_9144626 | 1.96 |
ENST00000543895.1
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
chr14_-_106331652 | 1.96 |
ENST00000390565.1
|
IGHJ1
|
immunoglobulin heavy joining 1 |
chr14_-_106539557 | 1.95 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
chr6_+_63921351 | 1.95 |
ENST00000370659.1
|
FKBP1C
|
FK506 binding protein 1C |
chr5_+_135394840 | 1.95 |
ENST00000503087.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr21_+_10862622 | 1.94 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
chr2_-_85890569 | 1.92 |
ENST00000494165.1
|
SFTPB
|
surfactant protein B |
chr16_+_28943260 | 1.92 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
chr15_-_44969086 | 1.91 |
ENST00000434130.1
ENST00000560780.1 |
PATL2
|
protein associated with topoisomerase II homolog 2 (yeast) |
chr22_-_37571089 | 1.90 |
ENST00000453962.1
ENST00000429622.1 ENST00000445595.1 |
IL2RB
|
interleukin 2 receptor, beta |
chr18_-_68317947 | 1.90 |
ENST00000594039.1
ENST00000582578.1 |
GTSCR1
|
Gilles de la Tourette syndrome chromosome region, candidate 1 |
chr1_-_114414316 | 1.90 |
ENST00000528414.1
ENST00000538253.1 ENST00000460620.1 ENST00000420377.2 ENST00000525799.1 ENST00000359785.5 |
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
chr7_-_142181009 | 1.89 |
ENST00000390368.2
|
TRBV6-5
|
T cell receptor beta variable 6-5 |
chr2_-_89459813 | 1.88 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr7_-_150329421 | 1.88 |
ENST00000493969.1
ENST00000328902.5 |
GIMAP6
|
GTPase, IMAP family member 6 |
chr3_+_46412345 | 1.88 |
ENST00000292303.4
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene) |
chr6_-_25930819 | 1.88 |
ENST00000360488.3
|
SLC17A2
|
solute carrier family 17, member 2 |
chr19_+_41497178 | 1.86 |
ENST00000324071.4
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6 |
chr14_-_94856951 | 1.85 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr15_-_55563072 | 1.83 |
ENST00000567380.1
ENST00000565972.1 ENST00000569493.1 |
RAB27A
|
RAB27A, member RAS oncogene family |
chr13_-_41593425 | 1.83 |
ENST00000239882.3
|
ELF1
|
E74-like factor 1 (ets domain transcription factor) |
chr12_+_10124001 | 1.82 |
ENST00000396507.3
ENST00000304361.4 ENST00000434319.2 |
CLEC12A
|
C-type lectin domain family 12, member A |
chr12_-_96390063 | 1.82 |
ENST00000541929.1
|
HAL
|
histidine ammonia-lyase |
chrX_-_19689106 | 1.81 |
ENST00000379716.1
|
SH3KBP1
|
SH3-domain kinase binding protein 1 |
chr12_-_10282681 | 1.81 |
ENST00000533022.1
|
CLEC7A
|
C-type lectin domain family 7, member A |
chr3_+_128779610 | 1.81 |
ENST00000307395.4
|
GP9
|
glycoprotein IX (platelet) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.0 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
1.9 | 9.7 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
1.7 | 6.6 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
1.2 | 6.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.2 | 3.5 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.1 | 5.6 | GO:0032796 | uropod organization(GO:0032796) |
0.9 | 7.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.9 | 6.2 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.9 | 0.9 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.9 | 3.5 | GO:0002290 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
0.8 | 6.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.8 | 2.5 | GO:2000224 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
0.8 | 3.3 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.8 | 2.4 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.8 | 2.3 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.8 | 10.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.8 | 131.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.8 | 2.3 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.8 | 3.0 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.8 | 4.5 | GO:0014806 | smooth muscle hyperplasia(GO:0014806) |
0.7 | 2.2 | GO:1901656 | glycoside transport(GO:1901656) |
0.7 | 3.5 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.7 | 8.4 | GO:0072564 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.7 | 1.4 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.7 | 2.8 | GO:0090294 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.7 | 2.0 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.6 | 0.6 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.6 | 7.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.6 | 3.1 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.6 | 1.9 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.6 | 3.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 3.6 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.6 | 2.4 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.6 | 3.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.6 | 2.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.6 | 1.7 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.6 | 7.4 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.6 | 1.7 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.6 | 1.7 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.6 | 2.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 1.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.5 | 4.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.5 | 1.6 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.5 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.5 | 2.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.5 | 1.5 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.5 | 1.0 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.5 | 3.5 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.5 | 2.5 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.5 | 1.5 | GO:0002818 | intracellular defense response(GO:0002818) |
0.5 | 3.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.5 | 3.0 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.5 | 2.5 | GO:0039650 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.5 | 6.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.5 | 1.9 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.5 | 1.4 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.5 | 1.4 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.5 | 2.3 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.5 | 1.4 | GO:0071529 | cementum mineralization(GO:0071529) |
0.4 | 2.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.4 | 1.8 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.4 | 2.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.4 | 0.4 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.4 | 1.3 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.4 | 1.7 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) negative regulation of activation of membrane attack complex(GO:0001971) |
0.4 | 0.9 | GO:0002605 | negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
0.4 | 6.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 2.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.4 | 3.8 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 5.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.4 | 1.3 | GO:0070408 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
0.4 | 0.8 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.4 | 2.5 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.4 | 2.0 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.4 | 2.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 3.6 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.4 | 1.2 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.4 | 2.0 | GO:0071724 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.4 | 2.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.4 | 0.8 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.4 | 2.4 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.4 | 1.9 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.4 | 1.9 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.4 | 2.2 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.4 | 1.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.4 | 1.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.4 | 4.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 76.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 1.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.4 | 1.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.4 | 0.7 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.3 | 1.4 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.3 | 4.5 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.3 | 1.4 | GO:0071231 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) cellular response to folic acid(GO:0071231) |
0.3 | 4.8 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.3 | 2.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.3 | 1.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 3.5 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 4.4 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 3.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.3 | 0.3 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.3 | 5.5 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.3 | 1.5 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.3 | 1.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 1.2 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.3 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 1.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 4.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.3 | 0.9 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
0.3 | 3.8 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 1.1 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.3 | 0.9 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.3 | 1.4 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.3 | 4.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.3 | 2.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.3 | 1.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.3 | 1.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.3 | 0.3 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.3 | 1.1 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.3 | 1.9 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 3.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 2.9 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 0.5 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.3 | 1.3 | GO:0070942 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
0.3 | 0.8 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.3 | 15.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 0.5 | GO:0052314 | isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
0.3 | 1.8 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) positive regulation of constitutive secretory pathway(GO:1903435) |
0.3 | 2.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.3 | 1.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 1.0 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.2 | 3.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.0 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.2 | 0.7 | GO:0045556 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.2 | 0.5 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.2 | 1.0 | GO:0007059 | chromosome segregation(GO:0007059) |
0.2 | 1.0 | GO:0051413 | response to cortisone(GO:0051413) |
0.2 | 0.7 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
0.2 | 3.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 0.7 | GO:0005997 | xylulose metabolic process(GO:0005997) D-xylose metabolic process(GO:0042732) |
0.2 | 1.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 0.5 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.2 | 6.9 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 1.4 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.2 | 1.4 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.2 | 1.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 1.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.2 | 0.9 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.2 | 0.7 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.2 | 2.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.6 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.2 | 0.6 | GO:2001189 | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
0.2 | 1.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 1.9 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 1.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 2.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 0.4 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.2 | 1.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.6 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.2 | 1.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 1.2 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 2.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 1.0 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 | 0.4 | GO:2001183 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
0.2 | 1.6 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 0.8 | GO:0052418 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.2 | 14.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 4.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.6 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.2 | 1.7 | GO:0034201 | response to oleic acid(GO:0034201) |
0.2 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 2.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 1.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.7 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
0.2 | 0.9 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.2 | 0.9 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.7 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.2 | 3.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 0.7 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.2 | 14.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 1.8 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.2 | 1.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 1.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.9 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.2 | 0.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.2 | 0.7 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.2 | 0.8 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.2 | 0.5 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.2 | 4.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 0.7 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.2 | 0.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.8 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.5 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.2 | 1.8 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 3.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.2 | 1.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 1.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.2 | 0.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.8 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.2 | 0.5 | GO:0015709 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.2 | 0.5 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.2 | 3.5 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 0.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.2 | 0.8 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.2 | 0.5 | GO:0005985 | sucrose metabolic process(GO:0005985) |
0.2 | 4.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 1.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.8 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.2 | 0.5 | GO:1904344 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
0.2 | 4.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 1.5 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.6 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.1 | 1.0 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 2.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.7 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 | 0.4 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.1 | 0.4 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.1 | 1.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.7 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 1.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 2.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.1 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.1 | 1.1 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.1 | 0.7 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 3.0 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 0.8 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 1.0 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.1 | 4.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.8 | GO:0048514 | blood vessel morphogenesis(GO:0048514) |
0.1 | 1.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.3 | GO:1903401 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
0.1 | 0.5 | GO:2000866 | negative regulation of macrophage chemotaxis(GO:0010760) positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.1 | 0.8 | GO:1903299 | regulation of glucokinase activity(GO:0033131) negative regulation of glucokinase activity(GO:0033132) regulation of hexokinase activity(GO:1903299) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.8 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 1.3 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 0.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 14.0 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.6 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 1.0 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.1 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.1 | 1.1 | GO:1902748 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.1 | 3.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 3.0 | GO:0021924 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.1 | 1.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.5 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 2.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 2.8 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.4 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.1 | 3.1 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.1 | 1.8 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.6 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.6 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.1 | 0.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.5 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 1.7 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.9 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.1 | 0.3 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.5 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 0.6 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.1 | 0.2 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) negative regulation of interleukin-17 production(GO:0032700) |
0.1 | 0.5 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.1 | 0.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.6 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 3.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.1 | 0.2 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 0.8 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 0.5 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.1 | 3.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.5 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.1 | 1.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.2 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 1.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.6 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.4 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.8 | GO:0036337 | Fas signaling pathway(GO:0036337) regulation of Fas signaling pathway(GO:1902044) |
0.1 | 0.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 3.0 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.5 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.1 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.1 | 0.3 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.1 | 0.8 | GO:0015822 | mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
0.1 | 0.5 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.1 | 0.3 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.1 | 1.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.4 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 0.6 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 0.5 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.1 | 2.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 2.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.7 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 1.9 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 1.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.3 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.1 | 1.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 0.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.1 | 0.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.3 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.1 | 0.4 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 2.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.4 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.5 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 1.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 1.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 1.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.6 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.1 | 2.2 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 1.0 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.3 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.1 | 0.7 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.2 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.5 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 1.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.4 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.1 | 0.4 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.1 | 0.3 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.1 | 0.2 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 0.9 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 2.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 1.4 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.1 | 0.6 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.1 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 1.8 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.4 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 1.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 5.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 1.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.4 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.1 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 1.0 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 3.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 17.7 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.3 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 0.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.2 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.1 | 0.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 1.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 0.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.2 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 1.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 2.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.2 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.9 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 1.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.8 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 1.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.1 | 1.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 1.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.2 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
0.1 | 0.6 | GO:0050651 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 4.6 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.6 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 1.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.3 | GO:0002449 | lymphocyte mediated immunity(GO:0002449) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.1 | 0.2 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
0.1 | 2.0 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.1 | 0.5 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.1 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.1 | 0.3 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 2.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.5 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.1 | 0.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.6 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.1 | 0.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.3 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 1.4 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.2 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 1.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 1.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.2 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.1 | 0.2 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.0 | 2.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.0 | 0.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.0 | 1.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.9 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.0 | 0.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.6 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.3 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 1.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.7 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 0.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0031348 | negative regulation of defense response(GO:0031348) |
0.0 | 0.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.0 | 0.0 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.0 | 0.2 | GO:0044107 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.0 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.0 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.0 | 0.2 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.9 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.2 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.0 | 0.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 1.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 1.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.3 | GO:0042325 | regulation of phosphorylation(GO:0042325) |
0.0 | 0.4 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.5 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.2 | GO:0032053 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
0.0 | 0.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 1.0 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.5 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.0 | 2.3 | GO:0051250 | negative regulation of lymphocyte activation(GO:0051250) |
0.0 | 2.4 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.0 | 2.6 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.9 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 1.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 1.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.0 | 0.1 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.5 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 1.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.3 | GO:0046349 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.1 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.0 | 0.7 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.3 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 1.0 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 1.8 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.3 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.1 | GO:0070895 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
0.0 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.0 | 0.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 1.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 3.5 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.0 | 0.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 1.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.4 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.1 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.0 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.4 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.3 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.0 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.4 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.0 | 0.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 1.5 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.7 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 1.4 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.5 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 3.6 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.0 | 0.2 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.2 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 1.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.6 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.6 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.0 | 0.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.2 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.1 | GO:0060356 | leucine import(GO:0060356) |
0.0 | 0.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.7 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.0 | GO:0034402 | mRNA export from nucleus in response to heat stress(GO:0031990) recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.0 | 0.1 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.0 | 0.3 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 1.0 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.1 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 1.1 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.2 | GO:0010226 | response to lithium ion(GO:0010226) |
0.0 | 0.3 | GO:0045765 | regulation of angiogenesis(GO:0045765) |
0.0 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 1.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0070541 | response to platinum ion(GO:0070541) |
0.0 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.0 | 0.9 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.0 | 8.6 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.3 | GO:0072662 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.2 | GO:1903557 | positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
0.0 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.6 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.7 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.0 | 0.5 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 0.1 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 2.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.3 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.1 | GO:1901029 | adenine transport(GO:0015853) negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.3 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.0 | 0.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.6 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 0.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.5 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.4 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.2 | GO:0006959 | humoral immune response(GO:0006959) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.8 | 10.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 4.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.7 | 0.7 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.6 | 5.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 1.9 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.6 | 7.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 2.8 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.5 | 5.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.5 | 1.4 | GO:0036398 | TCR signalosome(GO:0036398) |
0.5 | 1.9 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.5 | 4.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 2.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.4 | 10.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 31.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 1.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 90.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 1.4 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.3 | 1.7 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 1.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 2.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.0 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.3 | 0.9 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 0.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.3 | 1.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 1.8 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.3 | 5.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 3.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 1.9 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 3.6 | GO:0061702 | inflammasome complex(GO:0061702) |
0.2 | 6.6 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 1.5 | GO:0044194 | cytolytic granule(GO:0044194) phagocytic vesicle lumen(GO:0097013) |
0.2 | 0.6 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.2 | 19.8 | GO:0035580 | specific granule lumen(GO:0035580) |
0.2 | 0.8 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.2 | 0.8 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 6.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 18.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.2 | 3.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.2 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.2 | 1.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 6.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 1.6 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.6 | GO:0060171 | myosin I complex(GO:0045160) stereocilium membrane(GO:0060171) |
0.1 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.4 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.1 | 2.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 1.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 16.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 1.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 0.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.4 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 1.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 33.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 3.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.3 | GO:0043614 | multi-eIF complex(GO:0043614) translation preinitiation complex(GO:0070993) glial limiting end-foot(GO:0097451) |
0.1 | 0.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 3.0 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 0.7 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.7 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 2.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.6 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 3.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.8 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 2.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.2 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 7.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 8.8 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 0.8 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 1.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 6.4 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 12.8 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.1 | 0.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 1.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 2.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 1.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.8 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 1.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 1.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 1.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 1.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.1 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.0 | 5.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 3.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.5 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 3.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 8.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 1.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 69.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 6.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 1.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 2.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.4 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.3 | GO:0032432 | stress fiber(GO:0001725) actin filament bundle(GO:0032432) contractile actin filament bundle(GO:0097517) |
0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.5 | GO:0044327 | dendritic spine membrane(GO:0032591) dendritic spine head(GO:0044327) |
0.0 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 3.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 1.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 0.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 1.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.0 | 0.8 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.0 | 0.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 0.2 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 2.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.5 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.5 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 1.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 3.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 4.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 5.2 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
2.1 | 6.2 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
2.0 | 6.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.5 | 7.3 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
1.4 | 5.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
1.3 | 6.6 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
1.1 | 4.2 | GO:0019862 | IgA binding(GO:0019862) |
0.9 | 5.5 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.9 | 2.7 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.9 | 2.7 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.9 | 2.7 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.9 | 6.1 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
0.9 | 3.5 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.8 | 2.4 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.8 | 2.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.8 | 2.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.8 | 8.4 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.7 | 3.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.7 | 191.5 | GO:0003823 | antigen binding(GO:0003823) |
0.7 | 2.8 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.7 | 2.8 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.7 | 5.9 | GO:0034618 | arginine binding(GO:0034618) |
0.6 | 2.4 | GO:0017129 | triglyceride binding(GO:0017129) |
0.6 | 3.0 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.6 | 2.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.6 | 4.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 1.6 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
0.5 | 3.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.5 | 2.1 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.5 | 1.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 8.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 12.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 5.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 2.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.4 | 1.8 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.4 | 2.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 0.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.4 | 3.0 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.4 | 1.7 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.4 | 2.0 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.4 | 1.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 2.0 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.4 | 13.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 0.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.4 | 2.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.4 | 2.2 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.4 | 1.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 2.5 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.3 | 1.4 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.3 | 1.4 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.3 | 1.7 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.3 | 1.0 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.3 | 2.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.3 | 1.3 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.3 | 0.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 2.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 1.3 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.3 | 1.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 4.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 1.8 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.3 | 0.9 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.3 | 3.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.3 | 0.9 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.3 | 1.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 0.8 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.3 | 5.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.3 | 1.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.3 | 2.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 8.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 0.8 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.3 | 0.8 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.2 | 1.0 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.2 | 9.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 1.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.7 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.2 | 0.9 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.2 | 2.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.4 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 0.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 7.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 1.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 1.8 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 4.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 4.9 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 1.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.2 | 0.9 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.2 | 0.9 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.2 | 2.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.7 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.2 | 1.3 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.2 | 0.6 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.2 | 1.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 3.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.6 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.2 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.6 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 1.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.2 | 1.4 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.2 | 1.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 0.6 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.8 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.2 | 1.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 2.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.7 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.2 | 1.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 3.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 6.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) triplex DNA binding(GO:0045142) |
0.2 | 0.5 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.2 | 1.7 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.9 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 3.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.2 | 0.8 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.2 | 1.3 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.5 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 1.2 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.2 | 1.0 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.2 | 0.7 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 3.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 2.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.6 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 8.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 0.5 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.2 | 0.5 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.2 | 0.5 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 1.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.5 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.2 | 6.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 2.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.2 | 3.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 0.5 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.2 | 1.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 3.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.9 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 3.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 2.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.4 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.4 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.1 | 6.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.4 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.1 | 0.3 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 2.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.0 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.5 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
0.1 | 0.4 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.1 | 0.7 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 1.2 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.1 | 1.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 1.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 19.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.1 | 1.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.5 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 0.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 1.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 3.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.6 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 0.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 1.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 6.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.4 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 1.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 6.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 1.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.5 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 3.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 2.1 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.5 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.1 | 0.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 3.3 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.4 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.1 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.1 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.3 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
0.1 | 0.4 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
0.1 | 1.7 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 2.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 1.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 2.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 2.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 2.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.3 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.2 | GO:0004040 | amidase activity(GO:0004040) |
0.1 | 0.2 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.1 | 0.5 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 1.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 1.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.5 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.4 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 2.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 1.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 1.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 3.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 1.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.1 | GO:0005503 | all-trans retinal binding(GO:0005503) |
0.1 | 0.5 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 3.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 15.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 1.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.1 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 0.2 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.1 | 0.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 1.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.5 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.5 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.0 | 0.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.3 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.0 | 0.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.6 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.9 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.5 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.4 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
0.0 | 0.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 1.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.3 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.0 | 1.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 2.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 6.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 2.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 1.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 1.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 2.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.8 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 4.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 1.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 2.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.0 | 0.2 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.0 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 1.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.0 | 0.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.0 | 0.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.0 | 10.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 1.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.0 | 3.3 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 2.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 1.4 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 1.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.4 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 1.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 1.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 1.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.4 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.2 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.0 | 0.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 1.0 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.3 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.8 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 2.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 1.7 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.0 | 0.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 7.1 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.1 | GO:0004325 | ferrochelatase activity(GO:0004325) |
0.0 | 2.2 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
0.0 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 1.8 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.0 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.0 | 0.7 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 1.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 1.9 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.0 | 0.1 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.0 | 1.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.3 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.0 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 12.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 12.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 1.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 6.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 24.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 2.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 14.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 3.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 22.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 8.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 11.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 10.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 11.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 5.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 3.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 4.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 2.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 10.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 4.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 2.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 2.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 4.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 6.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 7.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 8.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.7 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 21.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 5.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 3.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 3.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 5.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 2.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 5.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 2.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 1.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 8.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 2.1 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 2.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 7.3 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 12.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 8.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 6.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 10.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 9.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 20.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 3.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 5.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 7.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 4.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 7.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 4.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 3.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 4.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 15.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 3.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 5.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 6.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 2.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 6.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 7.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 3.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 9.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 3.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 26.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 2.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 7.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 2.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 2.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 3.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 2.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 7.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 15.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 2.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.7 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 2.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 6.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 2.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 5.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 2.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 18.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 3.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 3.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 5.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 14.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 1.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 2.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 1.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 1.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 2.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 4.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 2.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 1.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 2.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 2.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 5.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 2.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 2.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 2.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 2.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 2.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 1.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 2.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |